Chromatin acetylation, memory, and LTP are impaired in CBP+/- mice:: A model for the cognitive deficit in Rubinstein-Taybi syndrome and its amelioration

被引:685
作者
Alarcón, JM
Malleret, G
Touzani, K
Vronskaya, S
Ishii, S
Kandel, ER [1 ]
Barco, A
机构
[1] Columbia Univ, Ctr Neurobiol & Behav, Coll Phys & Surg, New York, NY 10032 USA
[2] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA
[3] RIKEN, Tsukuba Inst, Genet Mol Lab, Tsukuba, Ibaraki 3050074, Japan
关键词
D O I
10.1016/j.neuron.2004.05.021
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We studied a mouse model of the haploinsufficiency form of Rubinstein-Taybi syndrome (RTS), an inheritable disorder caused by mutations in the gene encoding the CREB binding protein (CBP) and characterized by mental retardation and skeletal abnormalities. In these mice, chromatin acetylation, some forms of long-term memory, and the late phase of hippocampal long-term potentiation (L-LTP) were impaired. We ameliorated the L-LTP deficit in two ways: (1) by enhancing the expression of CREB-dependent genes, and (2) by inhibiting histone deacetyltransferase activity (HDAC), the molecular counterpart of the histone acetylation function of CBP. Inhibition of HDAC also reversed the memory defect observed in fear conditioning. These findings suggest that some of the cognitive and physiological deficits observed on RTS are not simply due to the reduction of CBP during development but may also result from the continued requirement throughout life for both the CREB co-activation and the histone acetylation function of CBP.
引用
收藏
页码:947 / 959
页数:13
相关论文
共 49 条
  • [1] Bannister AJ, 1995, ONCOGENE, V11, P2509
  • [2] Rolipram, a type IV-specific phosphodiesterase inhibitor, facilitates the establishment of long-lasting long-term potentiation and improves memory
    Barad, M
    Bourtchouladze, R
    Winder, DG
    Golan, H
    Kandel, E
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) : 15020 - 15025
  • [3] Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture
    Barco, A
    Alarcon, JM
    Kandel, ER
    [J]. CELL, 2002, 108 (05) : 689 - 703
  • [4] A mouse model of Rubinstein-Taybi syndrome: Defective long-term memory is ameliorated by inhibitors of phosphodiesterase 4
    Bourtchouladze, R
    Lidge, R
    Catapano, R
    Stanley, J
    Gossweiler, S
    Romashko, D
    Scott, R
    Tully, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (18) : 10518 - 10522
  • [5] Chan HM, 2001, J CELL SCI, V114, P2363
  • [6] PHOSPHORYLATED CREB BINDS SPECIFICALLY TO THE NUCLEAR-PROTEIN CBP
    CHRIVIA, JC
    KWOK, RPS
    LAMB, N
    HAGIWARA, M
    MONTMINY, MR
    GOODMAN, RH
    [J]. NATURE, 1993, 365 (6449) : 855 - 859
  • [7] Molecular analysis of the CBP gene in 60 patients with Rubinstein-Taybi syndrome
    Coupry, I
    Roudaut, C
    Stef, M
    Delrue, MA
    Marche, M
    Burgelin, I
    Taine, L
    Cruaud, C
    Lacombe, D
    Arveiler, B
    [J]. JOURNAL OF MEDICAL GENETICS, 2002, 39 (06) : 415 - 421
  • [8] Ferrante RJ, 2003, J NEUROSCI, V23, P9418
  • [9] CREB-binding protein p300 are transcriptional coactivators of p65
    Gerritsen, ME
    Williams, AJ
    Neish, AS
    Moore, S
    Shi, Y
    Collins, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) : 2927 - 2932
  • [10] GOTTS EE, 1977, BIOL PSYCHIAT, V12, P413